138 related articles for article (PubMed ID: 20171567)
1. How activity of inflammatory bowel disease influences bone loss.
Orlic ZC; Turk T; Sincic BM; Stimac D; Cvijanovic O; Maric I; Tomas MI; Jurisic-Erzen D; Licul V; Bobinac D
J Clin Densitom; 2010; 13(1):36-42. PubMed ID: 20171567
[TBL] [Abstract][Full Text] [Related]
2. Updated bone mineral density status in Saudi patients with inflammatory bowel disease.
Ewid M; Al Mutiri N; Al Omar K; Shamsan AN; Rathore AA; Saquib N; Salaas A; Al Sarraj O; Nasri Y; Attal A; Tawfiq A; Sherif H
World J Gastroenterol; 2020 Sep; 26(35):5343-5353. PubMed ID: 32994692
[TBL] [Abstract][Full Text] [Related]
3. Reduced bone mass and preserved marrow adipose tissue in patients with inflammatory bowel diseases in long-term remission.
Bastos CM; Araújo IM; Nogueira-Barbosa MH; Salmon CEG; de Paula FJA; Troncon LEA
Osteoporos Int; 2017 Jul; 28(7):2167-2176. PubMed ID: 28405731
[TBL] [Abstract][Full Text] [Related]
4. Analysis of risk factors for low bone mineral density in inflammatory bowel disease.
Frei P; Fried M; Hungerbuhler V; Rammert C; Rousson V; Kullak-Ublick GA
Digestion; 2006; 73(1):40-6. PubMed ID: 16543736
[TBL] [Abstract][Full Text] [Related]
5. Role of ghrelin and insulin-like growth factor binding protein-3 in the development of osteoporosis in inflammatory bowel disease.
Koutroubakis IE; Zavos C; Damilakis J; Papadakis G; Neratzoulakis J; Karkavitsas N; Kouroumalis EA
J Clin Gastroenterol; 2011 Jul; 45(6):e60-5. PubMed ID: 20921904
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory bowel disease has a small effect on bone mineral density and risk for osteoporosis.
Targownik LE; Bernstein CN; Nugent Z; Leslie WD
Clin Gastroenterol Hepatol; 2013 Mar; 11(3):278-85. PubMed ID: 23103821
[TBL] [Abstract][Full Text] [Related]
7. Bone mineral density in Iranian patients with inflammatory bowel disease.
Zali M; Bahari A; Firouzi F; Daryani NE; Aghazadeh R; Emam MM; Rezaie A; Shalmani HM; Naderi N; Maleki B; Sayyah A; Bashashati M; Jazayeri H; Zand S
Int J Colorectal Dis; 2006 Dec; 21(8):758-66. PubMed ID: 16463035
[TBL] [Abstract][Full Text] [Related]
8. Bone mineral density in patients with inflammatory bowel disease: a population-based prospective two-year follow-up study.
Jahnsen J; Falch JA; Mowinckel P; Aadland E
Scand J Gastroenterol; 2004 Feb; 39(2):145-53. PubMed ID: 15000276
[TBL] [Abstract][Full Text] [Related]
9. The frequency of low bone mineral density and its associated risk factors in patients with inflammatory bowel diseases.
Ezzat Y; Hamdy K
Int J Rheum Dis; 2010 Aug; 13(3):259-65. PubMed ID: 20704624
[TBL] [Abstract][Full Text] [Related]
10. Frequency of low bone mineral density in Saudi patients with inflammatory bowel disease.
Ismail MH; Al-Elq AH; Al-Jarodi ME; Azzam NA; Aljebreen AM; Al-Momen SA; Bseiso BF; Al-Mulhim FA; Alquorain A
Saudi J Gastroenterol; 2012; 18(3):201-7. PubMed ID: 22626800
[TBL] [Abstract][Full Text] [Related]
11. Decreased trabecular bone mineral density in newly diagnosed inflammatory bowel disease patients in Korea.
Lee SH; Kim HJ; Yang SK; Kim WH; Joo YS; Dong SH; Kim BH; Lee JI; Chang YW; Chang R
J Gastroenterol Hepatol; 2000 May; 15(5):512-8. PubMed ID: 10847438
[TBL] [Abstract][Full Text] [Related]
12. Osteopenia and osteoporosis in Crohn's disease: prevalence in a Dutch population-based cohort.
Schoon EJ; van Nunen AB; Wouters RS; Stockbrügger RW; Russel MG
Scand J Gastroenterol Suppl; 2000; (232):43-7. PubMed ID: 11232491
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for decreased bone mineral density in inflammatory bowel disease: A cross-sectional study.
Wada Y; Hisamatsu T; Naganuma M; Matsuoka K; Okamoto S; Inoue N; Yajima T; Kouyama K; Iwao Y; Ogata H; Hibi T; Abe T; Kanai T
Clin Nutr; 2015 Dec; 34(6):1202-9. PubMed ID: 25618799
[TBL] [Abstract][Full Text] [Related]
14. Evolution of osteopenia in inflammatory bowel disease.
Dinca M; Fries W; Luisetto G; Peccolo F; Bottega F; Leone L; Naccarato R; Martin A
Am J Gastroenterol; 1999 May; 94(5):1292-7. PubMed ID: 10235209
[TBL] [Abstract][Full Text] [Related]
15. Bone loss in patients with inflammatory bowel disease is less than expected: a follow-up study.
Schulte C; Dignass AU; Mann K; Goebell H
Scand J Gastroenterol; 1999 Jul; 34(7):696-702. PubMed ID: 10466881
[TBL] [Abstract][Full Text] [Related]
16. Bone loss in patients with inflammatory bowel disease: a prospective study.
Roux C; Abitbol V; Chaussade S; Kolta S; Guillemant S; Dougados M; Amor B; Couturier D
Osteoporos Int; 1995 May; 5(3):156-60. PubMed ID: 7655175
[TBL] [Abstract][Full Text] [Related]
17. Combination therapy with an immunomodulator and anti-TNFα agent improves bone mineral density in IBD patients.
Krajcovicova A; Hlavaty T; Killinger Z; Miznerova E; Toth J; Letkovsky J; Nevidanska M; Cierny D; Koller T; Zelinkova Z; Huorka M; Payer J
J Crohns Colitis; 2014 Dec; 8(12):1693-701. PubMed ID: 25175812
[TBL] [Abstract][Full Text] [Related]
18. Risk Factors of Low Bone Mineral Density in Newly Diagnosed Pediatric Inflammatory Bowel Disease.
Ahn MB; Yoo IH
Nutrients; 2023 Dec; 15(24):. PubMed ID: 38140307
[TBL] [Abstract][Full Text] [Related]
19. Frequency, risk factors, and adverse sequelae of bone loss in patients with ostomy for inflammatory bowel diseases.
Gupta S; Wu X; Moore T; Shen B
Inflamm Bowel Dis; 2014 Feb; 20(2):259-64. PubMed ID: 24378598
[TBL] [Abstract][Full Text] [Related]
20. Chemerin, visfatin, and vaspin serum levels in relation to bone mineral density in patients with inflammatory bowel disease.
Terzoudis S; Malliaraki N; Damilakis J; Dimitriadou DA; Zavos C; Koutroubakis IE
Eur J Gastroenterol Hepatol; 2016 Jul; 28(7):814-9. PubMed ID: 26934527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
